Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Oct 2025 – 20 Aug 2026, limited by Groww Multi Asset Allocation Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Multi Asset Allocation Fund | Nifty 50 |
|---|---|---|
| 03 Oct 2025 | ₹100.00 | ₹100.00 |
| 30 Oct 2025 | ₹100.58 | ₹103.95 |
| 26 Nov 2025 | ₹101.72 | ₹105.27 |
| 22 Dec 2025 | ₹103.33 | ₹105.13 |
| 18 Jan 2026 | ₹104.09 | ₹103.21 |
| 14 Feb 2026 | ₹103.99 | ₹102.32 |
| 13 Mar 2026 | ₹98.69 | ₹93.00 |
| 08 Apr 2026 | ₹100.13 | ₹96.40 |
| 05 May 2026 | ₹100.60 | ₹96.54 |
| 01 Jun 2026 | ₹100.10 | ₹93.93 |
| 28 Jun 2026 | ₹100.34 | ₹96.63 |
| 24 Jul 2026 | ₹100.01 | ₹95.47 |
| 20 Aug 2026 | ₹103.34 | ₹97.34 |
| Metric | Groww · Regular NAV ₹10.35 High risk Unrated | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| — | +13.66% | |
| — | +15.55% | |
| — | +13.48% | |
| — | +11.02% | |
| +3.34% | +12.56% | |
| +3.99% | — | |
| — | +14.34% | |
| — | +11.77% | |
| — | +10.03% | |
| Risk | ||
| 12.47% | 10.32% | |
| — | 0.81 | |
| — | 1.11 | |
| -12.63% | -12.33% | |
| Nifty 50 | — | |
| — | +7.29% | |
| — | 0.62 | |
| — | 83.8% | |
| — | 24.4% | |
| 2.68% | 2.15% | |
| ₹404.74Cr | ₹2,048Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 351% | 53% | |
| Nikhil Satam | — | |
| 03 Oct 2025 | — | |
| 75 | — | |
| 24.2% | — | |
| 14.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.